Clinical Trial Update: Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Rina-S versus investigator's choice therapy in endometrial cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Rina-S

Snippet

Sponsor: Genmab | Conditions: Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | Phase 3 | Status: RECRUITING